Scarica l'app Stockscreener
189.91
0.98%
1.84
Pre-mercato:
191.00
1.09
+0.57%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DHR Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$188.07
Aprire:
$186.75
Volume 24 ore:
7.09M
Relative Volume:
1.84
Capitalizzazione di mercato:
$135.91B
Reddito:
$23.82B
Utile/perdita netta:
$3.77B
Rapporto P/E:
36.88
EPS:
5.15
Flusso di cassa netto:
$4.90B
1 W Prestazione:
-1.53%
1M Prestazione:
-3.30%
6M Prestazione:
-22.23%
1 anno Prestazione:
-24.31%
Intervallo 1D:
$185.50
$196.33
Intervallo di 1 settimana:
$185.50
$196.33
Portata 52W:
$171.00
$281.70
Danaher Corp Stock (DHR) Company Profile
Nome
Danaher Corp
Settore
Industria
Telefono
(202) 828-0850
Indirizzo
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Confronta DHR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
|
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-03-14 | Aggiornamento | Stifel | Hold → Buy |
| 2025-02-03 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-31 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Iniziato | HSBC Securities | Hold |
| 2023-12-13 | Ripresa | Wolfe Research | Peer Perform |
| 2023-12-07 | Downgrade | Goldman | Buy → Neutral |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-01 | Iniziato | SVB Securities | Outperform |
| 2023-04-26 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-04-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-10-24 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-08-17 | Ripresa | Bernstein | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-06-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Iniziato | Bernstein | Outperform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-10 | Reiterato | BofA Securities | Buy |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-23 | Reiterato | Goldman | Buy |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-04-07 | Ripresa | Robert W. Baird | Outperform |
| 2021-03-03 | Ripresa | Barclays | Overweight |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Ripresa | Stifel | Hold |
| 2019-10-28 | Reiterato | Needham | Buy |
| 2019-10-14 | Ripresa | Credit Suisse | Outperform |
| 2019-07-19 | Reiterato | Needham | Buy |
| 2019-06-11 | Iniziato | Piper Jaffray | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-04-17 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2019-02-25 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-03 | Iniziato | Needham | Buy |
| 2018-04-20 | Reiterato | Stifel | Buy |
Mostra tutto
Danaher Corp Borsa (DHR) Ultime notizie
Danaher (NYSE:DHR) Shares Unloaded Rep. Pete Sessions - MarketBeat
Danaher Corp (DHR) Q2 2025 Earnings Call Highlights: Strong Cash Flow and Bioprocessing Growth ... - Yahoo.co
Danaher Raises 2025 Earnings Outlook - The Motley Fool
Danaher Raises 2025 Earnings Outlook - Nasdaq
Top Manufacturing Stocks To ConsiderJuly 22nd - MarketBeat
Danaher Beats Q2 Revenue, EPS Forecasts - Nasdaq
Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth, Cost Discipline - Yahoo Finance
Danaher lifts annual profit forecast on pharma demand, China recovery - TradingView
Beacon Investment Advisory Services Inc. Sells 27,393 Shares of Danaher Corporation (NYSE:DHR) - MarketBeat
Danaher Corp. Exceeds Q2 Earnings Expectations with $555 Million ProfitNews and Statistics - IndexBox
Sustainable Growth Advisers LP Sells 709,054 Shares of Danaher Corporation (NYSE:DHR) - MarketBeat
DeDora Capital Inc. Cuts Stake in Danaher Corporation (NYSE:DHR) - MarketBeat
Danaher Reports Second Quarter 2025 Results - ADVFN Brasil
Danaher Corporation (NYSE:DHR) Shares Bought by KLP Kapitalforvaltning AS - MarketBeat
Alecta Tjanstepension Omsesidigt Grows Position in Danaher Corporation (NYSE:DHR) - MarketBeat
Steven Cohen's Strategic Moves: A Closer Look at Danaher Corp's Impact on His Portfolio - Yahoo.co
Danaher Corporation (NYSE:DHR) Shares Sold by VCI Wealth Management LLC - MarketBeat
Danaher Ups Profit Outlook Despite China Slowdown And Cost Pressures - Finimize
Danaher (DHR) Q2 2025 Earnings Call Transcript - The Globe and Mail
Bank Julius Baer & Co. Ltd Zurich Sells 147,134 Shares of Danaher Corporation (NYSE:DHR) - MarketBeat
Danaher Lifts Profit Outlook But Shares Slip Anyway - Finimize
Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y - Yahoo.co
Universal Beteiligungs und Servicegesellschaft mbH Has $189.86 Million Stake in Danaher Corporation (NYSE:DHR) - MarketBeat
Danaher Raises Profit Outlook Despite Market Concerns - Finimize
Danaher's Focus on Continuous Improvement Helps Set It Apart From Peers - Morningstar
Danaher Stock Surge: Key Factors to Watch - StocksToTrade
Danaher lifts annual profit view on strength in diagnostics, names new CFO - 104.1 WIKY
What drives Danaher Corporation stock priceTriple-digit wealth increases - jammulinksnews.com
PFG Advisors Has $6.09 Million Holdings in Danaher Corporation (NYSE:DHR) - MarketBeat
Earnings call transcript: Danaher Q2 2025 beats estimates, stock dips - Investing.com
Danaher Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Danaher (NYSE:DHR) Updates FY 2025 Earnings Guidance - MarketBeat
Danaher (DHR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Danaher Promotes Matthew Gugino to Finance Chief - Medical Product Outsourcing
Danaher 2025 Q2 Earnings Earnings Decline 37.4% Amid Revenue Growth - AInvest
Danaher (NYSE:DHR) Posts Earnings Results, Beats Expectations By $0.16 EPS - MarketBeat
Danaher Appoints Matthew Gugino as Chief Financial Officer - citybiz
US medtech group sent down despite upward adjustment - medwatch.com
Danaher stock slips despite Q2 beat (DHR:NYSE) - Seeking Alpha
OneAscent Financial Services LLC Acquires 2,255 Shares of Danaher Corporation (NYSE:DHR) - MarketBeat
Danaher Corporation Reports Better-than-Expected Results for Second Quarter 2025 - Tokenist
Danaher (DHR) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
Danaher: Q2 Earnings Snapshot - The Washington Post
Danaher Corp (DHR) Q2 2025 Earnings: Adjusted EPS of $1.80 Beats Estimates, Revenue Hits $5.9 Billion - GuruFocus
Danaher names Matthew Gugino as next CFO in planned transition - Investing.com
Earnings Snapshot: Danaher surpasses Q2 estimates; raises FY25 Adj. EPS outlook - Seeking Alpha
Danaher Q2 2025 slides: Biotechnology segment drives growth amid mixed results - Investing.com Canada
Danaher shares slip despite Q2 beat, annual profit outlook hike - Investing.com
Danaher’s (NYSE:DHR) Q2 Sales Top Estimates But Quarterly Revenue Guidance Slightly Misses Expectations - Yahoo Finance
Danaher Corp. Q2 Profit Decreases, But Beats Estimates - Nasdaq
Danaher earnings beat by $0.16, revenue topped estimates - Investing.com Nigeria
Danaher Corp Azioni (DHR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):